Wu T.-HCHIH-HSIN YANG2020-05-262020-05-2620181556-0864https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044146755&doi=10.1016%2fj.jtho.2018.02.009&partnerID=40&md5=d4f2eb96d43fb1d38366935c09aeae70https://scholars.lib.ntu.edu.tw/handle/123456789/494919[SDGs]SDG3adjuvant chemotherapy; cancer mortality; cancer research; cancer survival; clinical decision making; clinical practice; controlled clinical trial (topic); data base; Editorial; ethics; evidence based practice; human; ICD-10; ICD-9; mortality rate; observational method; patient safety; personalized medicine; priority journal; randomized controlled trial (topic); reliability; lung tumor; non small cell lung cancer; register; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Registrieseditorial10.1016/j.jtho.2018.02.009295762852-s2.0-85044146755